What the headline numbers actually tell you
If depression has continued despite treatment, it is reasonable to want a clear answer: does transcranial magnetic stimulation, or TMS, work? The research offers grounds for hope, but not a promise. In published trials, roughly half of patients respond and about a third reach remission.
Those are group results. They do not mean that a clinic can predict your outcome before treatment, or that every study finds the same result. For one person, the useful question is not simply whether TMS works. It is whether the evidence, assessment and practical demands make it a reasonable next step.
TMS has been FDA-cleared for major depressive disorder since 2008. FDA clearance and research findings matter, but neither guarantees that an individual will benefit. They also do not mean that every advertised treatment schedule has identical supporting evidence.
For patients in Nevada, the decision has another layer: getting to treatment repeatedly. A promising option still needs to fit around travel, work, family responsibilities and insurance. Reading the research honestly means keeping both the possible benefit and that commitment in view.
Response and remission are different outcomes
“Response” and “remission” are research terms, not interchangeable ways of saying that treatment worked.
- Response means a substantial reduction in symptoms, measured using the study’s chosen criteria. Someone can respond and still have depression symptoms that affect daily life.
- Remission means symptoms have fallen below the study’s threshold for depression. It does not, by itself, establish how long that improvement lasts.
The response and remission figures should not be added together. People who reach remission generally sit within the group who have responded; they are not an extra group of successful outcomes.
Ask what improvement would mean for you
Research measures make it possible to compare groups. Your goals may be more personal: managing everyday tasks, reconnecting with family, or feeling able to make plans. Before treatment, discuss how the clinic will track symptoms alongside the changes that matter to you.
Ask which symptom questionnaire the clinic uses, when it repeats it, and how you will review progress together. A lower score is useful information, but you should also have room to describe what has and has not changed.
Timing matters too. An outcome recorded at the end of a course answers a different question from an outcome recorded later. When someone quotes a remission rate, ask: “Remission at what point, and was there follow-up?” A single headline figure cannot tell you everything about recovery over time.
How to read a study or a clinic’s success rate
The figures of roughly half responding and about a third reaching remission are a useful starting point. They are not a benchmark that every clinic or patient group must match. Before treating any number as relevant to you, look at who was studied and how the result was calculated.
Who was included?
Check whether the research involved people with depression that had persisted after previous treatments. Ask how the study defined treatment resistance and whether participants’ treatment histories resemble yours. A label alone does not explain how many treatments were tried or how those trials were documented.
Other useful questions include whether participants continued other care and which TMS approach they received. These details help establish what the study tested; they should not be skipped in favour of its most encouraging number.
What was counted?
When a clinic describes its own outcomes, ask:
- Does the figure mean response, remission or something else?
- Were all patients who started included, or only those who completed treatment?
- How many patients contributed to the result?
- When were symptoms measured?
- Is this published research or the clinic’s own internal review?
Results based only on people who finish treatment leave unanswered questions about those who stop. A small group also provides a different basis for a claim from a larger study. Neither issue automatically makes a result useless, but both affect how confidently you can interpret it.
For research, ask whether there was a comparison group and what treatment it received. A before-and-after improvement figure does not answer exactly the same question as a controlled trial. You do not need to become a researcher: a clinic should be willing to explain these distinctions in plain language.
What the evidence means for your treatment decision
A group average cannot settle whether TMS is right for you. An assessment should connect the research to your history, current difficulties and preferences, rather than turn a published rate into a personal prediction.
Bring a record of previous antidepressants and psychotherapy, including what helped, what did not, and why treatments ended. If details are missing, ask your existing care team for help gathering them. This supports both the clinical discussion and possible insurance authorisation.
Useful questions for the consultation include:
- What evidence supports the approach you recommend for my depression?
- How will we assess progress during the course?
- What happens if improvement is limited?
- What follow-up will we discuss if I benefit?
A standard course is about 36 weekday sessions over 6–9 weeks, with sessions running roughly 3–20 minutes. Patients stay awake and can drive themselves home. Common side effects are scalp discomfort and headache; seizure is rare. Ask the clinician to explain the safety assessment and what to report during treatment.
Some clinics offer SAINT or accelerated theta burst schedules that compress treatment into days. If you are considering one, ask for evidence specific to that schedule. Do not assume that a general TMS response rate describes every accelerated approach.
Also keep the condition being treated clear. For example, TMS treatment for PTSD is off-label. Evidence or clearance for one indication should not be presented as proof for another.
Making a course workable in Nevada
The directory is concentrated in Las Vegas, with 25 clinics, and Reno, with 10. Henderson has six, North Las Vegas four, and Sparks and Carson City two each. Single clinics are listed in Elko, Fernley, Mesquite, Pahrump and Zephyr Cove.
These are directory locations, not a guarantee that each clinic offers the same protocols, accepts your insurance or is taking new patients. Confirm those details before organising travel.
For patients in rural counties without a listed TMS clinic, treatment may mean travelling to Las Vegas, Reno or Carson City. Nevada consistently ranks near the bottom for mental health workforce availability, and most rural counties are federally designated mental health professional shortage areas. Distance is therefore a meaningful part of the decision, not a minor inconvenience.
A session may be short while the overall appointment commitment is substantial. Before starting, map out the journey for repeated weekday visits. Ask about appointment scheduling, what happens after a missed visit, and how the clinic coordinates with your existing mental health care.
If family members are helping, agree on practical support in advance. Even when you can drive yourself home, help with childcare or daily responsibilities may make attendance more manageable. Compare clinics on the feasibility of completing care, not only on a quoted success rate.
Insurance and the questions to take forward
Many insurers typically require documented failure of two or more antidepressant trials plus psychotherapy, as well as prior authorisation. Requirements vary, so ask the clinic to confirm the rules for your particular plan before treatment begins.
Nevada Medicaid and Nevada Check Up are the state programmes. Medicaid managed care in urban counties runs through contracted health plans. Ask the clinic to confirm whether it participates in your plan, whether the proposed treatment requires authorisation, and what costs you could be responsible for. Do not assume that authorisation for one schedule extends to another.
Veterans can ask the VA Southern Nevada Healthcare System in North Las Vegas or the VA Sierra Nevada Health Care System in Reno about assessment and referral options. Confirm what is available through your care team rather than assuming a particular treatment is offered.
When comparing options, keep three questions together: How relevant is the evidence to me? How will we judge benefit? Can I realistically complete the proposed course?
Roughly half responding and about a third reaching remission is meaningful evidence, but it leaves uncertainty. A sound decision does not require certainty. It requires an honest discussion of possible benefit, the demands of treatment, and a clear plan for reviewing what happens next.